Irvine group creates enzyme for efficient synthetic genetic material production
"TNA's resilience to enzymatic and chemical degradation positions it as the ideal candidate for developing new treatments such as therapeutic aptamers, a promising drug class that binds to target molecules with high specificity. Engineering enzymes that facilitate the discovery of new approaches could address the limitations of antibodies, such as improved tissue penetration, and potentially have an even greater positive impact on human health." (John Chaput)
